NsGene is committed to developing novel biological products for the treatment of neurological diseases and is focusing on Alzheimer’s disease, Parkinson's disease and sensorineural hearing loss.
NsGene is developing unique treatment options based on the proprietary technology EC Biodelivery(TM), an advanced platform for delivery of therapeutic macromolecules behind the blood-brain-barrier, into the cochlea, or at other sites difficult to reach by conventional drug delivery methods.
http://nsgene.dk
Details
Employees
13
Founded
1999
Industry
biotechnology research
Keywords
developing novel biologics and delivery methods for the treatment of neurological disorders.
Browse SuperAGI Directories
AI Native CRM for Unified Sales, Support & Marketing
Accelerate growth and streamline your entire stack with AI CRM Platform